The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...
In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, highlights data presented at Retina Subspecialty Day.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) sells medicines for eye conditions, immune disorders, cancer, cardiovascular issues, infections, and rare diseases.
Scientists have discovered why males get dental disease more frequently and with greater severity than females, pinpointing ...
Kiwifruit might be small, but it packs a mighty nutritional punch that can transform your health. This fuzzy little ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results